Company Information
| Company name | Aptahem AB |
| Business idea | Aptahem AB is a biotechnology company whose business concept is to develop aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company also carries out business development work towards future partners and licensees. The company’s main candidate, Apta-1, is developed as an emergency drug designed to prevent the progression of life-threatening organ- and tissue damages in sepsis patients. |
| CEO | Mikael Lindstam |
| Chairman of the Board | Kjell G Stenberg |
| Board of directors | Kjell G Stenberg Johan Lindh Cristina Glad Theresa Comiskey Olsen Mikael Lindstam |
| Number of employees | 6 |
| Organisation number | 556970-5782 |
| Article of association | Bolagsordning 2017-06-07 |
| Address | Norra Vallgatan 58, 4 tr |
| Zip code | 211 22 |
| City | Malmö |
| Website | www.aptahem.com |
| info@aptahem.com | |
| Phone | 0766 – 33 36 99 |
